Dr. Kohler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Children's Hospital Colorado
13123 E 16th Ave
Aurora, CO 80045Phone+1 720-777-6892Fax+1 720-777-7346
Education & Training
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 2014 - 2018
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2014 - 2018
- Johns Hopkins UniversityResidency, Pediatrics, 2011 - 2014
- Medical College of WisconsinClass of 2011
- Medical College of WisconsinPhD, Immunology , 2004 - 2009
- Rockhurst UniversityBS, Biology, Chemistry , Summa Cum Laude, 1997 - 2001
Certifications & Licensure
- CO State Medical License 2018 - 2025
- MD State Medical License 2014 - 2018
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Crystal Mackall Award for Pediatric Oncology Reserch Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, 2018
- Abstract Achievement Award American Society of Hematology, 2018
Publications & Presentations
PubMed
- 3 citationsOutcomes of Critically Ill Children With Acute Lymphoblastic Leukemia and Cytokine Release Syndrome Due to Chimeric Antigen Receptor T Cell Therapy: US, Multicenter PI...Grace E Logan, Kristen Miller, M Eric Kohler, Michele Loi, Aline B Maddux
Pediatric Critical Care Medicine. 2022-12-01 - 1 citationsCorrigendum to <Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia'>: <[Experimental Hematology 2021; 100: 1-11]>.Wenjuan Liao, M Eric Kohler, Terry Fry, Patricia Ernst
Experimental Hematology. 2021-11-01 - 19 citationsDoes lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemiaWenjuan Liao, M. Eric Kohler, Terry J. Fry, Patricia Ernst
Experimental Hematology. 2021-08-01
Books/Book Chapters
Abstracts/Posters
- A Direct Comparison of the In Vivo Efficacy and In Vitro Signaling of Chimeric Antigen Receptors and Endogenous T Cell Receptors.Kohler, ME, Yang, Y, Sepulveda, G, Fry, TJ., American Society of Hematology 59th Annual Meeting, Atlanta, GA, 12/2017
- Effect of Chronic Endogenous Antigen Stimulation on CAR T Cell Persistence and Memory FormationYang, Y, Kohler, ME, Fry, TJ, American Society of Hematology 59th Annual Meeting, Atlanta, GA, 12/2017
- Modeling Retreatment of Acute Lymphoblastic Leukemia with Anti-CD19 Chimeric Antigen Receptor T Cell TherapyYang, Y, Kohler, ME, Fry, TJ, American Society of Hematology 58th Annual Meeting, San Diego, CA, 12/2016
- Join now to see all
Press Mentions
- Health Crisis Has Created a Potential $250 Billion Telehealth OpportunitySeptember 16th, 2020
- CloudMD Is My TeleHealth StockApril 30th, 2020
- Hyundai Hope on Wheels Presents Children's Hospital Colorado with $200,000 Hyundai Young Investigator Grant to Support Pediatric Cancer ResearchSeptember 6th, 2019
Grant Support
- Paul Calabresi Clinical Scholars AwardUniversity of Colorado Cancer Center2019–2021
- Defining the signal transduction pathways of Chimeric Antigen Receptors (CAR) as a means to increase the efficacy of CAR T cell therapy for pediatric leukemiasHyundai Hope on Wheels2019–2021
- CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPGCancer League of Colorado2019–2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: